Among active 13F managers last quarter, 2 opened and 4 reduced; the largest holder to move was Citadel Advisors LLC (new position). No open-market insider trades in the last 180 days.
Funds lean out and no leg opposes.
22 tracked 13F filers disclose a position in NXL as of the latest SEC 13F filings, a combined $283K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Peak6 LLC | 240K | $79K | ▼−38% Reduced · −144K sh | Q2 2026 | |
| 2 | Geode Capital Management, LLC | 140K | $46K | ▼−43% Reduced · −107K sh | Q2 2026 | |
| 3 | Vanguard Capital Management LLC | 127K | $42K | —Held | Q2 2026 | |
| 4 | Citadel Advisors LLC | 75K | $25K | ▲New +75K sh | Q2 2026 | |
| 5 | Vanguard Fiduciary Trust Co | 51K | $17K | —Held | Q2 2026 | |
| 6 | State Street Corp | 32K | $11K | —Held | Q2 2026 | |
| 7 | Northern Trust Corp | 24K | $8K | —Held | Q1 2026 | |
| 8 | Kovack Advisors, Inc. | 22K | $8K | ▼−4.3% Reduced · −1K sh | Q2 2026 | |
| 9 | UBS Group AG | 22K | $8K | ▲+40% Added · +6K sh | Q1 2026 | |
| 10 | Susquehanna International Group, LLP | 21K | $7K | ▲+11% Added · +2K sh | Q1 2026 | |
| 11 | XTX Topco Ltd | 16K | $6K | ▲New +16K sh | Q1 2026 | |
| 12 | StoneX Group Inc. | 13K | $5K | ▼−41% Reduced · −9K sh | Q2 2026 | |
| 13 | Raymond James Financial Inc | 12K | $4K | ▲New +12K sh | Q1 2026 | |
| 14 | Renaissance Technologies LLC | 11K | $4K | ▼−91% Reduced · −111K sh | Q1 2026 | |
| 15 | Jane Street Group, LLC | 11K | $4K | ▼−70% Reduced · −25K sh | Q1 2026 | |
| 16 | LPL Financial LLC | 10K | $4K | ▼−0.3% Reduced · −34 sh | Q1 2026 | |
| 17 | Integrated Investment Consultants, LLC | 10K | $3K | —Held | Q2 2026 | |
| 18 | Tower Research Capital LLC (TRC) | 2K | $736 | ▼−9.7% Reduced · −226 sh | Q1 2026 | |
| 19 | Osaic Holdings, Inc. | 2K | $735 | ▼−11% Reduced · −250 sh | Q1 2026 | |
| 20 | Farther Finance Advisors, LLC | 1K | $355 | —Held | Q1 2026 | |
| 21 | Wells Fargo & Company | 1K | $348 | ▲New +1K sh | Q1 2026 | |
| 22 | Federation des caisses Desjardins du Quebec | 873 | $288 | ▲New +873 sh | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 2 funds opened a new position in NXL, while 4 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Apple IncAAPL | 8 funds | $3.4B |
| Nvidia CorpNVDA | 8 funds | $3.3B |
| Microsoft CorpMSFT | 8 funds | $1.7B |
| Micron Technology IncMU | 8 funds | $1.6B |
| Broadcom IncAVGO | 8 funds | $1.5B |
| Alphabet Inc-CL AGOOGL | 8 funds | $1.4B |
| Eli Lilly & CoLLY | 8 funds | $1.3B |
| Alphabet Inc-CL CGOOG | 8 funds | $1.1B |
| Chevron CorpCVX | 8 funds | $1.1B |
| JPMorgan Chase & CoJPM | 8 funds | $1.0B |
| Intel CorpINTC | 8 funds | $949.1M |
| Abbott LaboratoriesABT | 8 funds | $940.6M |
Ranked by how many of NXL's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in NXL.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Mar 12, 2025 | Shelton Carolyn Hamby | Sr. VP - Quality, Regulatory | Buy (P) | 6K | $13K |
| Feb 4, 2025 | Owens David | Chief Medical Officer, Director | Buy (P) 2 lots, same day | 2K | $6K |
| Jan 28, 2025 | Owens David | Chief Medical Officer, Director | Buy (P) | 2K | $4K |
| Jan 23, 2025 | Owens David | Chief Medical Officer, Director | Buy (P) | 1K | $3K |
| Jan 13, 2025 | Owens David | Chief Medical Officer, Director | Buy (P) | 2K | $5K |
| Oct 28, 2024 | Owens David | Chief Medical Officer, Director | Buy (P) | 500 | $1K |
| Aug 13, 2024 | Owens David | Chief Medical Officer, Director | Buy (P) | 1K | $950 |
| Jun 28, 2024 | Owens David | Chief Medical Officer, Director | Buy (P) | 1K | $2K |
| Jun 18, 2024 | Owens David | Chief Medical Officer, Director | Buy (P) | 2K | $1K |
| Jun 10, 2024 | Owens David | Chief Medical Officer, Director | Buy (P) 2 lots, same day | 3K | $2K |
| Sep 28, 2022 | Osser Leonard | Insider | Buy (P) | 10K | $11K |
| Sep 16, 2022 | Kazden Alan | Director | Buy (P) | 3K | $10K |
One row per insider, day and transaction code; shares and value are summed across the lots. Every lot is on the full insider page and in the filing.
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 2 | 9 | – |
Insiders Form 4 open-market | 0 | 0 | $0 |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for NXL
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/NXL/capital-change-brief"
Use Arkolith's capital_change_brief for NXL. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for NXL. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.